Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer
Petrelli, Annalisa;Bellomo, Sara Erika;Medico, Enzo;Berrino, Enrico;Provero, Paolo;Sapino, Anna;Giordano, Silvia;
2020-01-01
Abstract
Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020-MiR.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
1.69 MB
Formato
Adobe PDF
|
1.69 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
